Eagle Asset Management Inc Mirati Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$59.5 - $86.7 $99,127 - $144,442	1,666 Added 0.62%	270,209 $18.9 Million
Q2 2022 Aug 10, 2022	BUY	$39.16 - $88.71 $240,481 - $544,768	6,141 Added 2.34%	268,543 $18 Million
Q1 2022 May 12, 2022	BUY	$75.82 - $150.97 $272,497 - $542,586	3,594 Added 1.39%	262,402 $21.6 Million
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $92,142 - $132,822	-698 Reduced 0.27%	258,808 $38.4 Million
Q3 2021 Nov 10, 2021	BUY	$132.13 - $177.45 $34.3 Million - $46 Million	259,506 New	259,506 $45.9 Million
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $32.5 Million - $40.5 Million	-225,534 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $884,071 - $1.23 Million	5,563 Added 2.53%	225,534 $40.5 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $4.5 Million - $6.67 Million	-27,759 Reduced 11.21%	219,971 $48.3 Million
Q3 2020 Nov 12, 2020	SELL	$113.26 - $167.27 $3.11 Million - $4.59 Million	-27,424 Reduced 9.97%	247,730 $41.1 Million
Q2 2020 Aug 12, 2020	SELL	$72.01 - $120.39 $1.03 Million - $1.73 Million	-14,334 Reduced 4.95%	275,154 $31.6 Million
Q1 2020 May 11, 2020	BUY	$69.78 - $116.21 $159,377 - $265,423	2,284 Added 0.8%	289,488 $22.3 Million
Q4 2019 Feb 07, 2020	BUY	$70.76 - $128.86 $20.3 Million - $37 Million	287,204 New	287,204 $37 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.